by Peter Ciszewski | Oct 30, 2020
John Kuruvilla, MD, from the Princess Margaret Cancer Centre summarized the latest quality of life data from the Phase III KEYNOTE-204 Hodgkin lymphoma study comparing pembrolizumab to brentuximab vedontin. The study involved adults with relapsed or refractory...
by Peter Ciszewski | Oct 30, 2020
Michel Michaelides, MD, of UCL Institute of Ophthalmology; Moorfields Eye Hospital provides an overview of X-linked retinitis pigmentosa (XLRP), including its symptoms, common treatments, as well as a summary of the latest interim data from the MGT009 trial. ...
by Peter Ciszewski | Oct 29, 2020
Joslyn Crowe, Executive Director of the National Niemann-Pick Disease Foundation (NNPDF), talks about the programs the foundation has developed to help families be prepared when treatments get approved for Niemann-Pick disease. Niemann-Pick disease is a series...
by Peter Ciszewski | Oct 29, 2020
Rare Diseases Clinical Research Network (RDCRN) The Rare Diseases Clinical Research Network (RDCRN) is an NIH-funded research network of 20 active consortia or research groups. CheckRare is proud to be collaborating with the RDCRN to raise awareness of their programs....
by Peter Ciszewski | Oct 28, 2020
Thierry Abribat, PhD, chief executive officer of Amolyt Pharma provides an overview of hypoparathyroidism. Persons with hypoparathyroidism show abnormally low levels of calcium in the blood and high levels of phosphorus (hyperphosphatemia). Hypocalcemia can...
